Back

Core Scientific Seeks Shareholder Approval for $9 Billion CoreWeave Merger

CoreWeave reaffirms its $9 billion merger offer with Core Scientific, claiming it is the most secure path for long-term growth, despite opposition from Two Seas Capital.

Summary

CoreWeave has reaffirmed its commitment to acquiring Core Scientific under a $9 billion all-stock deal, emphasizing the merger’s potential for long-term value and risk mitigation. CoreWeave's open letter to shareholders stresses that independent operation would expose Core Scientific to execution risks. The deal is set for a vote on October 30, with CoreWeave urging shareholders to support the transaction despite opposition from Two Seas Capital, its largest shareholder. CoreWeave shares fell 1.5% in pre-market trading, while Core Scientific dropped 3%.

Terms & Concepts
  • All-Stock Acquisition: A type of merger where the acquiring company uses its own shares to pay for the acquired company, instead of offering cash.
  • Shareholder Approval: A formal vote by a company’s shareholders to authorize significant corporate actions, such as mergers or acquisitions.
  • Synergies: Cost savings or revenue enhancements that result when two companies combine their operations.